H1B Report
Side-by-side comparison

Baylor College of Medicine vs WIPRO LIMITED

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
Baylor College of Medicine
TXRank #152FEIN 74-1613878
Entity B
WIPRO LIMITED
NJRank #6FEIN 98-0154401

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricBaylor College of MedicineWIPRO LIMITED
Total filings3,29972,392
Certified %62.41%91.61%
Denied %1.70%0.37%
Withdrawn %3.64%1.37%
Cert-withdrawn %32.25%6.64%
Rank#152#6
Active yearsFY2010–FY2026FY2010–FY2026
Worksite stateTXNJ

Outcomes — Baylor College of Medicine

DOL case-status mix.

Outcome breakdown: Certified 62.4%, Cert-withdrawn 32.3%, Withdrawn 3.6%, Denied 1.7%
Outcome breakdown
OutcomeShare
Certified62.4%
Cert-withdrawn32.3%
Withdrawn3.6%
Denied1.7%
Certified62.4%
Cert-withdrawn32.3%
Withdrawn3.6%
Denied1.7%

Outcomes — WIPRO LIMITED

DOL case-status mix.

Outcome breakdown: Certified 91.6%, Cert-withdrawn 6.6%, Withdrawn 1.4%, Denied 0.4%
Outcome breakdown
OutcomeShare
Certified91.6%
Cert-withdrawn6.6%
Withdrawn1.4%
Denied0.4%
Certified91.6%
Cert-withdrawn6.6%
Withdrawn1.4%
Denied0.4%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Baylor College of Medicine
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY2010247
FY2011212
FY2012288
FY2013315
FY2014260
FY2015301
FY2016278
FY2017219
FY2018240
FY2019240
FY20200
FY20210
FY20220
FY202372
FY2024232
FY2025259
FY2026136
WIPRO LIMITED
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20103,039
FY20113,025
FY20127,031
FY20136,574
FY20148,104
FY201511,824
FY201610,254
FY20175,012
FY20186,067
FY20194,154
FY202094
FY2021128
FY202297
FY2023554
FY20242,296
FY20252,289
FY20261,850

Top 5 occupations — WIPRO LIMITED

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.